A recent study comparing the effects of knockdown of E2F1 in chronic myelocytic leukemia stem cells and normal marrow stem cells showed that unlike CML stem cells, normal marrow stem cells were unaffected by the knockdown of E2F1 [24]. This evidence concerns the gene E2F1 and chronic myelogenous leukemia, BCR-ABL1 positive.